Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The antiphospholipid syndrome].

K Ichikawa1

  • 1Department of Medicine II, Hokkaido University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework supporting the development of a Grid portal for analysis based on ROI.

Methods of information in medicine·2005
Same author

Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.

Gut·2005
Same author

A kinetic study of enhancing effect by phenolic compounds on the hydroxyl radical generation during ozonation.

Water science and technology : a journal of the International Association on Water Pollution Research·2004
Same author

Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Gut·2004
Same author

An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2004
Same author

Genetic evolution of alpha fetoprotein producing gastric cancer.

Journal of clinical pathology·2003
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Antiphospholipid antibodies are linked to antiphospholipid syndrome (APS), causing blood clots and pregnancy issues. These antibodies may trigger thrombosis by affecting blood vessel cells or accelerating atherosclerosis.

Area of Science:

  • Immunology and Rheumatology
  • Vascular Biology and Thrombosis

Context:

  • Antiphospholipid antibodies (aPL), including anticardiolipin antibodies and lupus anticoagulant, are prevalent in patients with systemic lupus erythematosus (SLE) and related autoimmune conditions.
  • The antiphospholipid syndrome (APS) is characterized by the presence of aPL, accompanied by thromboembolic events, recurrent fetal loss, or thrombocytopenia.

Purpose:

  • To elucidate the mechanisms by which antiphospholipid antibodies contribute to the pathogenesis of the antiphospholipid syndrome.
  • To explore the molecular interactions of antiphospholipid antibodies with key proteins like beta 2-glycoprotein I and prothrombin.
  • To understand how these antibodies may induce thrombotic events and influence vascular health.

Summary:

  • Studies indicate that anticardiolipin antibodies bind to beta 2-glycoprotein I, while certain lupus anticoagulants bind to beta 2-glycoprotein I or prothrombin.

Related Experiment Videos

  • Antiphospholipid antibodies may promote thrombosis by disrupting vascular endothelial cell function or accelerating atherosclerosis progression.
  • Current recommendations for preventing recurrent thrombosis in APS patients include anticoagulation with warfarin, heparin, or low-dose aspirin.

    • Impact:

    • Provides insights into the molecular basis of antiphospholipid syndrome, aiding in the development of targeted diagnostic and therapeutic strategies.
    • Highlights potential mechanisms for thrombosis in APS, informing clinical management and risk assessment.
    • Supports the continued use of anticoagulation therapies in managing APS, emphasizing the need for personalized treatment approaches.